Home › Ulcerative Colitis › Texas › Lubbock
Pag-aaral pangklinika para sa Ulcerative Colitis sa Lubbock, TX
9 pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Lubbock (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Site US-015, Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
- Xencor Investigative Site, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Nagre-recruitPhase 2
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Nagre-recruitPhase 4
- West Texas Research Institute, Lubbock
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Lubbock
Pag-aaral para sa Ulcerative Colitis sa ibang lungsod
- New York City, NY24 pag-aaral
- Orlando, FL23 pag-aaral
- Miami, FL22 pag-aaral
- Houston, TX18 pag-aaral
- San Antonio, TX16 pag-aaral
- San Diego, CA16 pag-aaral
- Tacoma, WA15 pag-aaral
- Chicago, IL15 pag-aaral
- Tyler, TX14 pag-aaral
- St. Louis, MO14 pag-aaral
- Colorado Springs, CO14 pag-aaral
- Los Angeles, CA13 pag-aaral
Iba pang pag-aaral sa Lubbock
- Crohn's Disease10 pag-aaral
- Kanser sa Suso6 pag-aaral
- Non-Small Cell Lung Cancer4 pag-aaral
- Psoriatic Arthritis3 pag-aaral
- Inflammatory Bowel Disease3 pag-aaral
- Burkitt Lymphoma3 pag-aaral
- Obesity3 pag-aaral
- Overweight3 pag-aaral
- Multiple Myeloma3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.